HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$41.45
Day range
$40.60 - $41.80
Year range
$14.06 - $41.91
Market cap
4.68B USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 348.00K | -98.80% |
Operating expense | 55.49M | 2.54% |
Net income | -72.00M | -332.54% |
Net profit margin | -20.69K | -36,085.89% |
Earnings per share | -0.53 | -222.35% |
EBITDA | -55.08M | -120.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 702.95M | 66.29% |
Total assets | 786.43M | 79.06% |
Total liabilities | 58.36M | -3.27% |
Total equity | 728.07M | — |
Shares outstanding | 113.39M | — |
Price to book | 6.45 | — |
Return on assets | -17.22% | — |
Return on capital | -18.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -72.00M | -332.54% |
Cash from operations | -32.77M | -162.11% |
Cash from investing | 2.51M | 3,441.33% |
Cash from financing | 5.89M | 10,058.62% |
Net change in cash | -24.15M | -202.66% |
Free cash flow | 3.68M | 130.05% |
About
Founded
2019
Website
Employees
77
